title: Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands.
authors.affiliation: PANAXEA, Enschede, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Kip
authors.affiliation: Bayer, Mijdrecht, The Netherlands.
authors.forename: den Bosch M
authors.initials: dB
authors.lastname: van
authors.affiliation: Van Creveldkliniek & Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Fischer
authors.affiliation: Beatrix Childrens Hospital, University Medical Center Groningen, Groningen, The Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: Tamminga
authors.affiliation: PANAXEA, Enschede, The Netherlands.
authors.forename: I
authors.initials: I
authors.lastname: Lepage-Nefkens